Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Applications
  3. blood collection
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Locations

  • USA
  • North America
Industries served

  • Medical / Health Care

Blood Collection Product Applications

5 applications found

Tasso for PopPK - Next-Generation Population Pharmacokinetic Studies

Tasso for PopPK - Next-Generation Population Pharmacokinetic Studies

Our virtually painless, clinical-grade blood collection devices drive recruitment and retention through an improved patient-centric experience that can be completed anywhere. ...

ByTasso, Inc.  based in  Seattle, WASHINGTON (USA)


Radio Frequency Sensor Technology for Diabetics

Radio Frequency Sensor Technology for Diabetics

We are revolutionizing the way you will manage your Type 2 diabetes, applying leading edge sensor and materials technologies to detect blood sugar levels and present them to you through Alertgy ...

ByAlertgy  based in  Melbourne, FLORIDA (USA)


Tasso for Pediatrics - Investigational Use Only

Tasso for Pediatrics - Investigational Use Only

Developed with feedback from nurses, pediatricians, and parents, Tasso’s pediatric sampling offers a convenient, virtually painless collection experience that eliminates needle phobia and blood volume concerns for research with ...

ByTasso, Inc.  based in  Seattle, WASHINGTON (USA)


Tasso Solutions

Tasso Solutions

A NEW WAY TO POWER YOUR DECENTRALIZED CLINICAL TRIALS; Unlock the power of anytime, anywhere blood testing for your program. Tasso Solutions streamline the deployment and execution of at-home testing for ...

ByTasso, Inc.  based in  Seattle, WASHINGTON (USA)


Diagnostic Solutions for Colorectal Cancer

Diagnostic Solutions for Colorectal Cancer

Standard treatment for advanced colorectal cancer generally involves surgical resection and chemotherapy. However, the recent emergence of targeted therapies, particularly those that inhibit EGFR, has provided treatment options that extend survival for a subset of patients. Unfortunately, this benefit does not extend to patients whose tumors contain mutations in EGFR signaling components KRAS and BRAF, which together represent 50% of all colorectal cancers. This makes characterizing these molecular markers an ...

ByBiocept   based in  San Diego, CALIFORNIA (USA)

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT